DANIEL ELBOGDADI

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology ROCKVILLE, MD NPI 1528186285

General Payments — all program years on this page

$22,185.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 248
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $534.68 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $534.6810

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $155.132
NOVARTIS PHARMACEUTICALS CORPORATION $137.401
Amgen Inc. $97.492
Lilly USA, LLC $95.572
ABBVIE INC. $35.302
UCB, Inc. $13.791

By program year

Program yearAmountRecords
2018 $5,630.28124
2019 $7,108.8569
2020 $44.573
2021 $55.783
2022 $825.6716
2023 $7,985.2023
2024 $534.6810

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086853009 Novartis Pharmaceuticals Corporation $137.40 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103683347 ABBVIE INC. $19.40 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103683349 ABBVIE INC. $15.90 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104575368 AstraZeneca Pharmaceuticals LP $81.90 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105651140 AstraZeneca Pharmaceuticals LP $73.23 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111568949 Amgen Inc. $23.46 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117547885 Amgen Inc. $74.03 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136140159 Lilly USA, LLC $78.19 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136140161 Lilly USA, LLC $17.38 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143264240 UCB, Inc. $13.79 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.